Online citations, reference lists, and bibliographies.
← Back to Search

Role Of The Membrane-associated Folate Binding Protein (folate Receptor) In Methotrexate Transport By Human KB Cells.

J. C. Deutsch, P. C. Elwood, R. Portillo, M. Macey, J. F. Kolhouse
Published 1989 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The uptake of methotrexate by KB cells was observed to be dependent on time, temperature, and concentration of extracellular methotrexate. The Kd for methotrexate surface binding to KB cells was approximately 200 nM. Following exposure of KB cells to trace quantities of [3H]methotrexate for periods ranging from 6 min to 24 h, the cellular methotrexate was progressively formed into methotrexate polyglutamates and was bound to dihydrofolate reductase as well as to a particulate folate binding protein. To further study the mechanism of methotrexate uptake in KB cells, the N-hydroxysuccinimide ester of methotrexate was used to covalently label the surface of KB cells and to inhibit transport of methotrexate. The N-hydroxysuccinimide ester of methotrexate was bound to a species of protein with an apparent molecular weight of 160,000 in 1% (v/v) Triton X-100 that bound folic acid and was specifically precipitated by antiserum raised against the previously purified high-affinity folate binding protein (the folate receptor) from human KB cells. In addition, trypsin was utilized to remove surface-accessible covalently bound methotrexate. The amount of covalently bound methotrexate that could be released by trypsin initially decreased on incubation at 37 degrees C, suggesting that the methotrexate and binding protein were internalized. However, with time, trypsin could again release the covalently bound methotrexate, suggesting that the binding protein cycles from the external cell surface to the inside of the cell and out again.
This paper references
10.7326/0003-4819-103-4-489
Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.
P. Andersen (1985)
10.1002/9780470122921.CH5
Transport of folate compounds in bacterial and mammalian cells.
F. M. Huennekens (1978)
10.1042/BJ1050633
A simple method for the preparation of 5-methyltetrahydropteroylglutamic acid.
I. Chanarin (1967)
10.1016/0005-2736(83)90267-5
Irreversible inhibitors of methotrexate transport in L1210 cells. Characteristics of inhibition by an N-hydroxysuccinimide ester of methotrexate.
G. Henderson (1983)
Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells.
M. McHugh (1979)
10.1016/0006-2952(87)90051-7
Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions.
F. Sirotnak (1987)
10.1021/BI00389A024
Photoaffinity analogues of methotrexate as folate antagonist binding probes. 2. Transport studies, photoaffinity labeling, and identification of the membrane carrier protein for methotrexate from murine L1210 cells.
E. M. Price (1987)
Recycling of photoaffinity-labeled insulin receptors in rat adipocytes. Dissociation of insulin-receptor complexes is not required for receptor recycling.
T. Huecksteadt (1986)
10.1001/JAMA.1964.03070100037007
METHOTREXATE THERAPY IN PSORIATIC ARTHRITIS; DOUBLE-BLIND STUDY ON 21 PATIENTS.
R. L. Black (1964)
10.1172/JCI113126
Identification of high affinity folate binding proteins in human erythrocyte membranes.
A. Antony (1987)
Isolation and characterization of a folate receptor from human placenta.
A. Antony (1981)
10.1016/s0021-9258(18)66727-4
The isolation, characterization, and comparison of the membrane-associated and soluble folate-binding proteins from human KB cells.
P. C. Elwood (1986)
Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line.
J. Schuetz (1988)
10.1016/s0021-9258(17)43082-1
Affinity labeling of the 5-methyltetrahydrofolate/methotrexate transport protein of L1210 cells by treatment with an N-hydroxysuccinimide ester of [3H]methotrexate.
G. Henderson (1984)
10.1056/NEJM198503283121303
Efficacy of low-dose methotrexate in rheumatoid arthritis.
M. Weinblatt (1985)
10.1016/s0021-9258(17)43440-5
Transport routes utilized by L1210 cells for the influx and efflux of methotrexate.
G. Henderson (1984)
10.1016/s0021-9258(18)95679-6
Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells.
A. Antony (1985)
10.1016/s0021-9258(18)33987-5
Isolation, characterization, and comparison of the solubilized particulate and soluble folate binding proteins from human milk.
A. Antony (1982)
Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
G. Jansen (1989)
10.1016/s0021-9258(18)91984-8
Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell.
I. Goldman (1968)
Transport of folate compounds in L1210 cells: kinetic evidence that folate influx proceeds via the high-affinity transport system for 5-methyltetrahydrofolate and methotrexate.
G. Henderson (1986)
10.1016/s0021-9258(17)42427-6
The influence of extracellular folate concentration on methotrexate uptake by human KB cells. Partial characterization of a membrane-associated methotrexate binding protein.
M. Kane (1986)



This paper is referenced by
Purification and Analysis of Folate-dye Conjugate
Dilipkumar Sakhiya (2010)
10.1042/BJ2860707
Immunoreactive folate-binding proteins from human saliva. Isolation and comparison of two distinct species.
R. S. Verma (1992)
10.1172/JCI115959
Transfection of a glycosylated phosphatidylinositol-anchored folate-binding protein complementary DNA provides cells with the ability to survive in low folate medium.
C. Luhrs (1992)
Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
G. Westerhof (1995)
Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
G. Westerhof (1991)
10.1177/10454411980090010201
Neural tube and craniofacial defects with special emphasis on folate pathway genes.
R. Finnell (1998)
10.1089/CBR.1998.13.427
99mTc-ethylenedicysteine-folate: a new tumor imaging agent. Synthesis, labeling and evaluation in animals.
S. Ilgan (1998)
10.1158/1055-9965.EPI-05-0260
Multivitamin and Alcohol Intake and Folate Receptor α Expression in Ovarian Cancer
L. Kelemen (2005)
10.1021/JM040187V
Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
T. Thomas (2005)
Folate Receptor-Targeting Liposomes for the Delivery of Antisense Molecules to Cancer Cells
Colin Way (2013)
Nové poznatky ve farmakologii methotrexátu – diagnostické možnosti a klinický význam
M. Řiháček (2015)
10.1007/978-1-4757-3505-5_16
Imaging of Anticancer Drugs for Therapeutic Response and Prognosis
D. Yang (2001)
10.1021/acs.bioconjchem.5b00046
Engineering Biomaterial-Drug Conjugates for Local and Sustained Chemotherapeutic Delivery.
J. Coburn (2015)
Multivitamin and alcohol intake and folate receptor alpha expression in ovarian cancer.
L. Kelemen (2005)
10.1016/0006-2952(93)90235-O
Altered folate-binding protein mRNA stability in KB cells grown in folate-deficient medium.
C. T. Hsueh (1993)
10.1007/s002800050483
Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate
Marie-France Pinard (1996)
10.1007/BF00020168
Methotrexate does not block import of a DHFR fusion protein into chloroplasts
T. America (2004)
10.1016/j.nucmedbio.2009.12.006
Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
S. Okarvi (2010)
10.1172/JCI115150
The folate receptor works in tandem with a probenecid-sensitive carrier in MA104 cells in vitro.
B. Kamen (1991)
10.1016/S0304-3835(01)00552-3
Overexpression of folate binding protein alpha is one of the mechanism explaining the adaptation of HT29 cells to high concentration of methotrexate.
M. de Nonancourt-Didion (2001)
10.1201/9781439832387.ch4
Pharmaceutical applications.
P. Lee (1991)
10.1038/s41467-018-04343-0
Rapid labelling and covalent inhibition of intracellular native proteins using ligand-directed N-acyl-N-alkyl sulfonamide
T. Tamura (2018)
10.1007/PL00005369
Characterization of the bile acid sensitive methotrexate carrier of rat liver cells
W. Honscha (1999)
10.1053/JHEP.2000.7478
Cloning and functional characterization of the bile acid–sensitive methotrexate carrier from rat liver cells
W. Honscha (2000)
10.1124/mol.113.088393
Cellular Uptake of the Antitumor Agent Dp44mT Occurs via a Carrier/Receptor-Mediated Mechanism
A. Merlot (2013)
10.1007/978-1-4615-2960-6_161
Identification of a reduced folate/methotrexate carrier in human KB-cells expressing high levels of membrane associated folate binding protein.
G. Westerhof (1993)
10.1182/blood-2008-04-150789
A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages.
Wei Xia (2009)
10.1172/JCI116327
Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.
K. Chung (1993)
10.1182/blood.v79.11.2807.bloodjournal79112807
The biological chemistry of folate receptors.
A. Antony (1992)
10.1074/JBC.270.7.2987
Isolation of a Human cDNA That Complements a Mutant Hamster Cell Defective in Methotrexate Uptake (*)
F. M. Williams (1995)
10.2174/1381612825666190710111658
Perspective and Potential of A2A and A3 Adenosine Receptors as Therapeutic Targets for the Treatment of Rheumatoid Arthritis.
Y. Pal (2019)
Purification and Analysis of Folate-Dye Conjugate
Sravya Mothe (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar